Recent Finacing
Recent Raise
Terremoto Biosciences is a clinical-stage biotechnology company developing highly targeted, small-molecule AKT1-selective inhibitors for oncology and rare disease.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
